Socio-economic Determinants for Acceptance and Choice of Biological Treatment
1 other identifier
observational
117
0 countries
N/A
Brief Summary
This was a cross-sectional study conducted at National center for rheumatic diseases, Nepal on SpA patient refractory to initial treatment with conventional anti rheumatic drugs. Patients taking TNFi (tumor necrosis factor inhibitor- adalimumab or etanercept) or tofacitinib were included. Baseline demographic, socio-economic, clinical data were recorded.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2015
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2019
CompletedFirst Submitted
Initial submission to the registry
April 28, 2020
CompletedFirst Posted
Study publicly available on registry
April 30, 2020
CompletedMay 1, 2020
April 1, 2020
4.6 years
April 28, 2020
April 29, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
socio economic determinants
socio economic determinants for acceptance of biologic therapy
four years
Eligibility Criteria
Patients with SpA and enrolled in the cohort database from June 2015 to December 2019 were selected.
You may qualify if:
- patients with spondyloarthropathy
- on any oral or injectable forms of biological treatment
You may not qualify if:
- less than 18years of age
- who did not consent for participation
- deferred from biological treatment due to comorbid conditions like concurrent infections or heart failure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Study coordinator
Study Record Dates
First Submitted
April 28, 2020
First Posted
April 30, 2020
Study Start
June 1, 2015
Primary Completion
December 31, 2019
Study Completion
December 31, 2019
Last Updated
May 1, 2020
Record last verified: 2020-04